CINA CHEST vs Autoplaque
AI Verdict
Choose CINA CHEST if…
Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for life-threatening acute chest conditions in an emergency setting. This tool excels at quickly detecting and prioritizing suspected Pulmonary Embolism and Aortic Dissection on CT angiography scans, enabling faster intervention for critical patients.
View CINA CHEST →Choose Autoplaque if…
Choose Autoplaque if your focus is on detailed, quantitative analysis of coronary plaques and luminal stenoses for comprehensive cardiovascular risk assessment and treatment planning. This workstation-based software provides in-depth characterization of atherosclerotic plaque from CT angiography images, supporting long-term patient management rather than acute emergency triage.
View Autoplaque →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CINA CHEST | Autoplaque |
|---|---|---|
| Pricing | Subscription-based | Unknown |
| Deployment | Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker) | Workstation-based post-processing application, runs on Windows or Mac OS. |
| FDA Status | K210237 AI-estimated | 1 AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CINA CHESTCINA CHEST operates as a standalone web application and provides notifications with preview images, suggesting a streamlined workflow for rapid triage. Autoplaque is workstation-based, requiring dedicated software installation and a more hands-on post-processing approach, which may be less immediately integrated into a fast-paced emergency workflow.
Clinical Value
CINA CHESTCINA CHEST focuses on the rapid detection and prioritization of life-threatening conditions like Pulmonary Embolism and Aortic Dissection, directly impacting emergency patient outcomes. While Autoplaque offers valuable quantitative analysis for heart attack risk prediction, its application is generally for chronic disease management and risk stratification, which is less time-critical than acute triage.
Pricing & Value
CINA CHESTCINA CHEST explicitly states a 'subscription-based' pricing model, indicating a clear commercialization strategy, even if specific details require a request. Autoplaque's pricing is 'not disclosed,' making it impossible to assess its value proposition or commercial availability for external customers.
Enterprise Readiness
CINA CHESTCINA CHEST is FDA-cleared, explicitly states HIPAA compliance, and offers flexible deployment options including cloud, on-premise, and virtualized environments, which are crucial for enterprise integration and scalability. Autoplaque lacks specified HIPAA compliance and BAA information, and its workstation-based deployment is less versatile for large-scale enterprise adoption.
Innovation
TieBoth tools demonstrate significant innovation by leveraging AI for advanced radiological image analysis. CINA CHEST's rapid triage for acute, life-threatening conditions is impactful for emergency workflows. Autoplaque's quantitative analysis of coronary plaques for risk prediction represents a sophisticated application of AI in chronic disease management. Both address distinct, complex clinical challenges with innovative AI solutions.
Support & Docs
CINA CHESTAvicenna.AI, the company behind CINA CHEST, highlights 24/7 support and dedicated customer success teams, indicating a robust commercial support structure. Information regarding specific support and documentation for Autoplaque, developed by Cedars-Sinai AIM, is not readily available or emphasized for external commercial use, suggesting a more academic or internal focus.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CINA CHEST | Autoplaque |
|---|---|---|
| Name | CINA CHEST | Autoplaque |
| Company | Avicenna.AI | Cedars-Sinai Medical Center: AIM |
| Primary Function | AI-powered radiological triage and notification software for rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. | AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. |
| Key Detections/Analysis | Detection of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans; Flags and communicates suspected positive findings. | Quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses. |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CINA CHEST and Autoplaque.